Rheumatic Disease Unit, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh EH42XU, UK.
Osteoporos Int. 2011 Mar;22(3):911-21. doi: 10.1007/s00198-010-1364-5. Epub 2010 Aug 27.
A meta-analysis of studies was conducted involving 24,511 participants with 7,864 fractures in which polymorphisms in the 5' flank of COL1A1 (rs1107946, rs2412298, and rs1800012) were related to osteoporosis phenotypes. Polymorphisms of all three sites were associated with BMD, and rs1800012 was associated with fracture but effect sizes were modest.
Polymorphisms in the 5' flank of COL1A1 gene have been implicated as genetic markers for susceptibility to osteoporosis, but previous studies have yielded conflicting results.
We conducted a meta-analysis of 32 studies including 24,511 participants and 7,864 fractures in which alleles at the -1997G/T (rs1107946), -1663in/delT (rs2412298), and Sp1 binding site polymorphisms (rs1800012) of COL1A1 had been related to bone mineral density (BMD) or fracture.
For the Sp1 polymorphism, BMD values in TT homozygotes were 0.13 units [95% CI, 0.03 to 0.24] lower at the spine (p = 0.01) and 0.16 units [0.10 to 0.23] lower at the hip (p = 1 x 10⁻⁶) than GG homozygotes. Clinical fractures were 1.31-fold [1.04-1.65] increased in TT homozygotes (p = 0.02) and vertebral fractures were 1.34-fold [1.01-1.77] increased (p = 0.04). We also observed associations between spine BMD and allelic variants at the -1997G/T (p = 0.05) and the -1663indelT (p = 0.009) sites. We found no association between alleles at the -1997G/T or -1663indelT sites and fracture but power was limited.
The COL1A1 Sp1 polymorphism is associated with a modest reduction in BMD and an increased risk of fracture, although we cannot fully exclude the possibility that the results may have been influenced by publication bias. Further studies are required to fully evaluate the contribution of the -1997G/T and -1663in/delT sites to these phenotypes and to determine if they interact with the Sp1 polymorphism to regulate susceptibility to osteoporosis.
对涉及24511名参与者和7864例骨折的研究进行了荟萃分析,其中COL1A1基因5'侧翼的多态性(rs1107946、rs2412298和rs1800012)与骨质疏松症表型相关。所有三个位点的多态性均与骨密度相关,rs1800012与骨折相关,但效应量较小。
COL1A1基因5'侧翼的多态性被认为是骨质疏松症易感性的遗传标记,但先前的研究结果相互矛盾。
我们对32项研究进行了荟萃分析,这些研究包括24511名参与者和7864例骨折,其中COL1A1基因-1997G/T(rs1107946)、-1663插入/缺失T(rs2412298)和Sp1结合位点多态性(rs1800012)的等位基因与骨密度(BMD)或骨折相关。
对于Sp1多态性,TT纯合子的脊柱骨密度值比GG纯合子低0.13个单位[95%置信区间,0.03至0.24](p = 0.01),髋部低0.16个单位[0.10至0.23](p = 1×10⁻⁶)。TT纯合子的临床骨折增加了1.31倍[1.04 - 1.65](p = 0.02),椎体骨折增加了1.34倍[1.01 - 1.77](p = 0.04)。我们还观察到-1997G/T(p = 0.05)和-1663插入/缺失T(p = 0.009)位点的等位基因与脊柱骨密度之间存在关联。我们发现-1997G/T或-1663插入/缺失T位点的等位基因与骨折之间没有关联,但检验效能有限。
COL1A1基因Sp1多态性与骨密度适度降低和骨折风险增加相关,尽管我们不能完全排除结果可能受到发表偏倚影响的可能性。需要进一步研究以全面评估-1997G/T和-1663插入/缺失T位点对这些表型的贡献,并确定它们是否与Sp1多态性相互作用以调节骨质疏松症易感性。